MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Widespread White Matter Changes in Manifest Huntington’s Disease

    S. Zadegan, TM. Cordeiro, E. Furr Stimming, A. Teixeira, N. Rocha (San Antonio, USA)

    Objective: To characterize white matter changes in Huntington’s Disease (HD). Background: HD is a genetic neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms. Diffusion Tensor…
  • 2025 International Congress

    Autonomic Nervous System Dysfunction in Patients with Huntington’s Disease: Preliminary Results Using the COMPASS-31 Scale

    J. Patino, S. Zadegan, N. Rocha, E. Furr Stimming (Houston, USA)

    Objective: To characterize dysautonomia-related symptoms in Huntington’s disease (HD) gene expansion carriers (HDGECs). Background: Autonomic nervous system (ANS) dysfunction is a recognized feature of HD…
  • 2025 International Congress

    Efficacy and Safety of Deutetrabenazine in Huntington’s Disease: a Systematic Review

    A. Viapiana, V. Müller, L. Lima, A. Petry, R. Juvêncio, A. Ribeiro, D. Gonçalves, M. da Rosa, G. Maia, V. Xavier (Porto Alegre, Brazil)

    Objective: To evaluate efficacy and safety of deutetrabenazine (DTB) in Huntington's Disease (HD) in order to guide evidence-based clinical decisions. Background: HD is a genetic…
  • 2025 International Congress

    Valbenazine Improves Chorea Across Multiple Body Regions in Adults With Huntington’s Disease

    E. Furr Stimming, E. Kayson, R. Mehanna, J. Goldstein, S. Hinton, O. Klepitskaya, H. Zhang, D. Haubenberger (Houston, USA)

    Objective: To evaluate valbenazine’s effects on chorea across body regions in adults with Huntington’s disease (HD) using data from KINECT®-HD (NCT04102579). Background: Once-daily valbenazine is…
  • 2025 International Congress

    A 37 years-old man with Epilepsy and Progressive Autoimmune Ataxia

    J. Balderas Juárez, A. Zepeda Rodríguez, R. Padilla García (Mexico City, Mexico)

    Objective: Describe a young patient with medial past history of Epilepsy who started with progressive symptoms of imbalance, vertigo, nausea, oscillopsy and recurrence of seizures.…
  • 2025 International Congress

    Brain Structural Impairment in Spinocerebellar Ataxia Type 6: Not Restricted to the Cerebellum

    B. Massuyama, T. Rezende, M. Junior, O. Barsottini, J. Pedroso (Campinas, Brazil)

    Objective: To characterize the structural brain signature in SCA6 patients. Background: Spinocerebellar ataxias (SCA) refer to a group of autosomal dominant ataxic disorders that result…
  • 2025 International Congress

    Correlations of plasma glial fibrillary acidic protein levels with glymphatic system impairment in Huntington’s disease

    JH. Yin, LY. Lu, Q. Yang, Y. Huang (Beijing, China)

    Objective: To investigate whether plasma glial fibrillary acidic protein (GFAP) levels are related to glymphatic system function in Huntington's disease (HD). Background: Plasma GFAP levels has…
  • 2025 International Congress

    Analysis of Emergency Department Encounters and Hospital Admissions of People with Huntington’s Disease

    T. Orem, E. Forbes, S. Sillau (Aurora, USA)

    Objective: Define characteristics of emergency department encounters and hospital admissions of people with Huntington’s disease and identify opportunities for intervention to reduce hospitalizations. Background: Huntington’s…
  • 2025 International Congress

    Clinical case of Sporadic adult-onset ataxia

    N. Aripova, L. Kenjaeva, B. Bakhtiyor, Y. Nishonova (Tashkent, Uzbekistan)

    Objective: To describe a clinical case of Sporadic adult-onset ataxia(SAOA) Background: Sporadic ataxia in adults is a heterogeneous neurological condition characterized by progressive impairment of…
  • 2025 International Congress

    Huntington disease in a Patient with Extensive Psychiatric History

    A. Sim, A. Drozdov, D. Carrillo, L. Acosta (El Paso, USA)

    Objective: Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder resulting from an expansion of CAG trinucleotide repeats in the gene encoding the huntingtin protein.…
  • « Previous Page
  • 1
  • …
  • 220
  • 221
  • 222
  • 223
  • 224
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley